Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Mar 1;9(2):123-129.
doi: 10.2217/pmt-2018-0050. Epub 2018 Nov 19.

Observational pilot study of patients with carpal tunnel syndrome treated with Nucleo CMP Forte™

M Povedano  1 , Y Martínez  1 , A Tejado  1 , P Arroyo  1 , C Tebe  2   3 , J L Lorenzo  4 , J Montero  1
Affiliations
Observational Study

Observational pilot study of patients with carpal tunnel syndrome treated with Nucleo CMP Forte™

M Povedano et al. Pain Manag. .

Abstract

Aim: Carpal tunnel syndrome (CTS) is a very common entrapment neuropathy characterized by pain and paresthesia in the territory of the median nerve. Although this syndrome has a considerable impact on the patient's quality of life, its medical treatment is far from optimal.

Material & methods: We performed an observational study to evaluate Nucleo CMP ForteTM in patients with electromyography-confirmed, mild-moderate CTS. Pain was assessed using a visual analog scale, electromyogram and the SF-36.

Results: Pain decreased significantly after 6 months. Quality of life improved significantly in the pain dimensions. No significant differences were observed in electromyographic findings. No adverse events were reported.

Conclusions: Nucleotides could prove useful for the nonsurgical treatment of CTS. Further studies are necessary to confirm this.

Keywords: carpal tunnel syndrome; electromyography; nucleotides; pain.

PubMed Disclaimer

Publication types

LinkOut - more resources